News

Safety Shot to Develop Detox Product for Alcohol Poising, Plans to File IND with U.S. FDA

Concentrated form of Safety Shot may be effective as a rapid treatment for alcohol poising which causes 2,200 deaths each…

1 year ago

Aptose to Present at the Cantor Global Healthcare Conference

SAN DIEGO and TORONTO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:…

1 year ago

Notice of Extraordinary General Meeting Promore Pharma AB (Publ)

STOCKHOLM, SWEDEN / ACCESSWIRE / September 18, 2023 / Promore Pharma (STO:PROMO) (FRA:8T0)Unofficial English translation for information purposes only. If…

1 year ago

AlzeCure Gets an Abstract on Phase II Clinical Data with ACD440 for Neuropathic Pain Accepted at Pain Conference

STOCKHOLM, SWEDEN / ACCESSWIRE / September 18, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), )…

1 year ago

Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC

· Prevail Partners, LLC to invest in Hemogenyx Pharmaceuticals.· Prevail InfoWorks, Inc. to act as Contract Research Organization (CRO) for…

1 year ago

Mydecine Innovations Group Files Prospectus Supplement

VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA)…

1 year ago

Digicann Ventures Announces Receipt of Last Portion of Final Earnout Milestone Payment

The Company Has Received the Last Portion of the Final Earnout Milestone Payment, With a Value of Approximately $1.5 Million…

1 year ago

SeqLL Announces Cash and Stock Dividend Record Date

BILLERICA, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (Nasdaq: SQL, SQLLW), announced today that…

1 year ago

Planet 13 Announces Completion of Change in Domicile to Nevada and OTC Market and Trading Symbol Change

LAS VEGAS, NV / ACCESSWIRE / September 15, 2023 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),…

1 year ago

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023

HILLSIDE, NJ / ACCESSWIRE / September 15, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial…

1 year ago